Annual Working Capital
$310.54 M
+$78.42 M+33.78%
31 December 2023
Summary:
Caribou Biosciences annual working capital is currently $310.54 million, with the most recent change of +$78.42 million (+33.78%) on 31 December 2023. During the last 3 years, it has fallen by -$54.82 million (-15.01%). CRBU annual working capital is now -15.01% below its all-time high of $365.36 million, reached on 31 December 2021.CRBU Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Working Capital
$205.27 M
-$34.67 M-14.45%
30 September 2024
Summary:
Caribou Biosciences quarterly working capital is currently $205.27 million, with the most recent change of -$34.67 million (-14.45%) on 30 September 2024. Over the past year, it has dropped by -$105.27 million (-33.90%). CRBU quarterly working capital is now -51.46% below its all-time high of $422.89 million, reached on 30 September 2021.CRBU Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CRBU Working Capital Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | -33.9% |
| 3 y3 years | -15.0% | -43.8% |
| 5 y5 years | +561.7% | - |
CRBU Working Capital High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -15.0% | +33.8% | -43.8% | at low |
| 5 y | 5 years | -15.0% | +2505.8% | -51.5% | +1622.5% |
| alltime | all time | -15.0% | +2505.8% | -51.5% | +1622.5% |
Caribou Biosciences Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $205.27 M(-14.4%) |
| June 2024 | - | $239.94 M(-12.9%) |
| Mar 2024 | - | $275.49 M(-11.3%) |
| Dec 2023 | $310.54 M(+33.8%) | $310.54 M(-4.8%) |
| Sept 2023 | - | $326.12 M(+39.3%) |
| June 2023 | - | $234.16 M(+10.3%) |
| Mar 2023 | - | $212.39 M(-8.5%) |
| Dec 2022 | $232.12 M | $232.12 M(-16.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2022 | - | $278.11 M(-14.2%) |
| June 2022 | - | $324.07 M(-5.1%) |
| Mar 2022 | - | $341.34 M(-6.6%) |
| Dec 2021 | $365.36 M(+2965.9%) | $365.36 M(-13.6%) |
| Sept 2021 | - | $422.89 M(+261.6%) |
| June 2021 | - | $116.96 M(-12.5%) |
| Mar 2021 | - | $133.72 M(+1022.1%) |
| Dec 2020 | $11.92 M(-74.6%) | $11.92 M |
| Dec 2019 | $46.93 M | - |
FAQ
- What is Caribou Biosciences annual working capital?
- What is the all time high annual working capital for Caribou Biosciences?
- What is Caribou Biosciences quarterly working capital?
- What is the all time high quarterly working capital for Caribou Biosciences?
- What is Caribou Biosciences quarterly working capital year-on-year change?
What is Caribou Biosciences annual working capital?
The current annual working capital of CRBU is $310.54 M
What is the all time high annual working capital for Caribou Biosciences?
Caribou Biosciences all-time high annual working capital is $365.36 M
What is Caribou Biosciences quarterly working capital?
The current quarterly working capital of CRBU is $205.27 M
What is the all time high quarterly working capital for Caribou Biosciences?
Caribou Biosciences all-time high quarterly working capital is $422.89 M
What is Caribou Biosciences quarterly working capital year-on-year change?
Over the past year, CRBU quarterly working capital has changed by -$105.27 M (-33.90%)